CMS Assesses Parallel Review; Device Industry Urges Continued Funding

CHICAGO – A CMS official told device industry representatives the agency plans to evaluate whether changes or improvements are needed to the FDA/CMS parallel review program, as the two agencies laud their first parallel review product approval and enter the last year of the pilot in 2015. Industry supporters of the program worry that its funding could end, and Exact Sciences Corporation – the one company that saw success with the program – is trying to build support on Capitol...